“…If this is achievable, autoantigen-derived prAPL can antigen-specifically restore the imbalance between autoreactive T cells and Treg cells in autoimmune diseases. TGF-β1 production was also demonstrated to be non-specifically induced in human monocytes upon treatment with ethanol [138,139]. In the case of ethanol, however, it is well known that ethanol increases the susceptibility of infection and other side effects and might be therefore not suitable for a therapeutic aspect.…”
Section: Application Of Apl In Situ and In Vivomentioning
SummaryBoth CD4 + and CD8 + T lymphocytes play a crucial role in the autoimmune process leading to T1D. Dendritic cells take up foreign antigens and autoantigens; within their endocytic compartments, proteases degrade exogenous antigens for subsequent presentation to CD4 + T cells via MHC class II molecules. A detailed understanding of autoantigen processing and the identification of autoantigenic T cell epitopes are crucial for the development of antigen-based specific immunomodulators. APL are peptide analogues of auto-immunodominant T cell epitopes that bind to MHC class II molecules and can mediate T cell activation. However, APL can be rapidly degraded by proteases occurring in the extracellular space and inside cells, substantially weakening their efficiency. By contrast, protease-resistant APL function as specific immunomodulators and can be used at low doses to examine the functional plasticity of T cells and to potentially interfere with autoimmune responses. Here, we review the latest achievements in (pro)-insulin processing in the MHC class II pathway and the generation of APL to mitigate autoreactive T cells and to activate Treg cells.
“…If this is achievable, autoantigen-derived prAPL can antigen-specifically restore the imbalance between autoreactive T cells and Treg cells in autoimmune diseases. TGF-β1 production was also demonstrated to be non-specifically induced in human monocytes upon treatment with ethanol [138,139]. In the case of ethanol, however, it is well known that ethanol increases the susceptibility of infection and other side effects and might be therefore not suitable for a therapeutic aspect.…”
Section: Application Of Apl In Situ and In Vivomentioning
SummaryBoth CD4 + and CD8 + T lymphocytes play a crucial role in the autoimmune process leading to T1D. Dendritic cells take up foreign antigens and autoantigens; within their endocytic compartments, proteases degrade exogenous antigens for subsequent presentation to CD4 + T cells via MHC class II molecules. A detailed understanding of autoantigen processing and the identification of autoantigenic T cell epitopes are crucial for the development of antigen-based specific immunomodulators. APL are peptide analogues of auto-immunodominant T cell epitopes that bind to MHC class II molecules and can mediate T cell activation. However, APL can be rapidly degraded by proteases occurring in the extracellular space and inside cells, substantially weakening their efficiency. By contrast, protease-resistant APL function as specific immunomodulators and can be used at low doses to examine the functional plasticity of T cells and to potentially interfere with autoimmune responses. Here, we review the latest achievements in (pro)-insulin processing in the MHC class II pathway and the generation of APL to mitigate autoreactive T cells and to activate Treg cells.
“…It is well known that alcohol consumption is able to trigger inflammatory effects on gastrointestinal tract interfering with mucosal homeostasis (Andrade et al, 2006;Cook, 1998;Coombes and Maloy, 2007;Lau et al, 2008;Watson et al, 1994). Previous reports from our group demonstrated that high-dose ethanol (EtOH) administration is able to induce an allergic-type inflammatory response in function of enhanced levels of seric IgE, high levels of gastric interleukin (IL)-4 and increased IL-4 synthesis by splenic T cells after in vitro unspecific stimulus (concanavalin A) (Andrade et al, 2006(Andrade et al, , 2008(Andrade et al, , 2009).…”
The present findings suggest that a priori ingestion of LL preserves essential mechanisms associated with oral tolerance induction that are disturbed by EtOH ingestion. Maintenance of mucosal homeostasis by preserving APC hierarchy and antigen presentation commitment could be associated with T-regulatory subset activities in the gastrointestinal tract.
“…In addition to effects on the liver, gastrointestinal, nervous, and cardiovascular systems, acute and chronic alcohol consumption has been found to cause numerous immunotoxic effects including decreased antigen-specific T-lymphocyte activation and proliferation, changes in T-lymphocyte cytokine synthesis and B-lymphocyte immunoglobulin production, and reduced granulocyte chemotactic and phagocytic activities [15][16][17][18][19][20][21][22][23][24][25][26][27] . Consequently, alcohol abuse has been associated with increased susceptibility to bacterial and viral infections and higher morbidity and mortality from a number of infectious diseases including tuberculosis, pneumonia, human immunodeficiency virus-1, and hepatitis C infections 17,26,28 .…”
Section: Introductionmentioning
confidence: 99%
“…They play a pivotal role in phagocytosis and killing of invading pathogenic microorganisms, moreover monocyte-derived macrophages are the most significant cells responsible for the engulfment and clearance of apoptotic cells 29,31 . Defects in monocyte functions have been proposed to contribute to the impaired anti-microbial defences noted in alcoholics 17,19,22,[25][26][27] . It has been reported that ethanol can suppress monocyte phagocytosis 22,25,32,33 .…”
Section: Introductionmentioning
confidence: 99%
“…Defects in monocyte functions have been proposed to contribute to the impaired anti-microbial defences noted in alcoholics 17,19,22,[25][26][27] . It has been reported that ethanol can suppress monocyte phagocytosis 22,25,32,33 . Although the consequences of the ethanol consumption are sufficient to cause concern for public health, less attention has been paid to the possible immunotoxic effects of the higher alcohols found in alcoholic beverages.…”
A large volume of alcoholic beverages containing aliphatic alcohols is consumed worldwide. Previous studies have confirmed the presence of ethanol-induced immunosuppression in heavy drinkers, thereby increasing susceptibility to infectious diseases. However, the aliphatic alcohols contained in alcoholic beverages might also impair immune cell function, thereby contributing to a further decrease in microbicidal activity. Previous research has shown that aliphatic alcohols inhibit phagocytosis by granulocytes but their effect on human monocytes has not been studied. This is important as they play a crucial role in engulfment and killing of pathogenic microorganisms and a decrease in their phagocytic activity could lead to impaired antimicrobial defence in heavy drinkers. The aim of this study was to measure monocyte phagocytosis following their treatment with those aliphatic alcohols detected in alcoholic beverages. Monocytes were separated from human peripheral blood and phagocytosis of opsonized zymosan particles by monocytes treated with ethanol and aliphatic alcohols individually and in combination was determined. It was shown that these alcohols could suppress the phagocytic activity of monocytes in a concentration-dependent manner and when combined with ethanol, they caused a further decrease in phagocytosis. Due to their additive effects, it is possible that they may inhibit phagocytosis in a clinically meaningful way in alcoholics and episodic heavy drinkers thereby contribute to their increased susceptibility to infectious diseases. However, further research is needed to address this question.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.